A new trading day began on Monday, with Enfusion Inc (NYSE: ENFN) stock price down -3.65% from the previous day of trading, before settling in for the closing price of $9.05. ENFN’s price has ranged from $7.52 to $10.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Technology Sector giant was 31.47%. Meanwhile, its annual earnings per share averaged 63.90%. With a float of $50.14 million, this company’s outstanding shares have now reached $88.33 million.
Let’s determine the extent of company efficiency that accounts for 1102 employees. In terms of profitability, gross margin is 66.94%, operating margin of 3.4%, and the pretax margin is 3.86%.
Enfusion Inc (ENFN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Software – Application Industry. The insider ownership of Enfusion Inc is 46.21%, while institutional ownership is 60.14%. The most recent insider transaction that took place on Oct 22 ’24, was worth 6,032. In this transaction General Counsel of this company sold 674 shares at a rate of $8.95, taking the stock ownership to the 53,627 shares. Before that another transaction happened on Oct 22 ’24, when Company’s Officer proposed sale 674 for $8.95, making the entire transaction worth $6,031.
Enfusion Inc (ENFN) Earnings and Forecasts
In its latest quarterly report, released on 6/30/2024, the company reported earnings of 0.04 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.90% per share during the next fiscal year.
Enfusion Inc (NYSE: ENFN) Trading Performance Indicators
Here are Enfusion Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.04. Likewise, its price to free cash flow for the trailing twelve months is 70.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.03, a number that is poised to hit 0.06 in the next quarter and is forecasted to reach 0.29 in one year’s time.
Technical Analysis of Enfusion Inc (ENFN)
Looking closely at Enfusion Inc (NYSE: ENFN), its last 5-days average volume was 0.4 million, which is a jump from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 29.25%. Additionally, its Average True Range was 0.28.
During the past 100 days, Enfusion Inc’s (ENFN) raw stochastic average was set at 38.20%, which indicates a significant increase from 8.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.23% in the past 14 days, which was lower than the 33.12% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.76, while its 200-day Moving Average is $8.86. However, in the short run, Enfusion Inc’s stock first resistance to watch stands at $9.05. Second resistance stands at $9.37. The third major resistance level sits at $9.57. If the price goes on to break the first support level at $8.53, it is likely to go to the next support level at $8.33. Should the price break the second support level, the third support level stands at $8.01.
Enfusion Inc (NYSE: ENFN) Key Stats
With a market capitalization of 1.14 billion, the company has a total of 128,410K Shares Outstanding. Currently, annual sales are 174,540 K while annual income is 6,030 K. The company’s previous quarter sales were 49,460 K while its latest quarter income was 1,830 K.
